A detailed history of Isthmus Partners, LLC transactions in Ingevity Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 74,831 shares of NGVT stock, worth $3.25 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
74,831
Previous 79,992 6.45%
Holding current value
$3.25 Million
Previous $3.5 Million 16.53%
% of portfolio
0.36%
Previous 0.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.91 - $47.24 $169,848 - $243,805
-5,161 Reduced 6.45%
74,831 $2.92 Million
Q2 2024

Aug 06, 2024

BUY
$43.47 - $55.12 $3.48 Million - $4.41 Million
79,992 New
79,992 $3.5 Million

Others Institutions Holding NGVT

About Ingevity Corp


  • Ticker NGVT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 38,048,800
  • Market Cap $1.65B
  • Description
  • Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells har...
More about NGVT
Track This Portfolio

Track Isthmus Partners, LLC Portfolio

Follow Isthmus Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Isthmus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Isthmus Partners, LLC with notifications on news.